Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
TEST:
P53 (TP53) Deletion FISH Probe Kit
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
Sysmex Corp
Type:
FDA Approved
Related tests:
‹
AML1/ETO (RUNX1/RUNX1T1) Translocation, Dual Fusion FISH Probe Kit
CBFβ (CBFB) /MYH11 Translocation, Dual Fusion FISH Probe Kit
Curebest™ 95GC Breast
DEL(5Q)Deletion Fish Probe Kit
Del(20Q) deletion fish probe Kit
Del(7q) Deletion FISH Probe Kit
EVI1 (MECOM) Breakapart Fish Probe Kit
MLL (KMT2A) Breakapart Fish Probe Kit
OncoBEAM EGFR v2 Kit
OncoBEAM RAS CRC kit
OncoBEAM™ BRAF Kit
OncoGuide™ NCC Oncopanel System
Plasma-SeqSensei™ CRC Kit
Plasma-SeqSensei™ NSCLC Kit
Plasma-SeqSensei™ Solid Cancer IVD Kit
RAS-RAF-SEQ Assay
SafeSEQ AML MRD Assay
SafeSEQ CRC MRD assay
SafeSEQ HNSCC assay
SafeSEQ HPV Test
SureSeq CLL + CNV V3 NGS Panel
SureSeq™ CLL + CNV Panel
SureSeq™ Germline Breast Cancer + CNV Panel
SureSeq™ Myeloid Fusion Panel
SureSeq™ Myeloid MRD Panel
SureSeq™ Myeloid Plus Panel
SureSeq™ Pan-Myeloid Panel
AML1/ETO (RUNX1/RUNX1T1) Translocation, Dual Fusion FISH Probe Kit
CBFβ (CBFB) /MYH11 Translocation, Dual Fusion FISH Probe Kit
Curebest™ 95GC Breast
DEL(5Q)Deletion Fish Probe Kit
Del(20Q) deletion fish probe Kit
Del(7q) Deletion FISH Probe Kit
EVI1 (MECOM) Breakapart Fish Probe Kit
MLL (KMT2A) Breakapart Fish Probe Kit
OncoBEAM EGFR v2 Kit
OncoBEAM RAS CRC kit
OncoBEAM™ BRAF Kit
OncoGuide™ NCC Oncopanel System
Plasma-SeqSensei™ CRC Kit
Plasma-SeqSensei™ NSCLC Kit
Plasma-SeqSensei™ Solid Cancer IVD Kit
RAS-RAF-SEQ Assay
SafeSEQ AML MRD Assay
SafeSEQ CRC MRD assay
SafeSEQ HNSCC assay
SafeSEQ HPV Test
SureSeq CLL + CNV V3 NGS Panel
SureSeq™ CLL + CNV Panel
SureSeq™ Germline Breast Cancer + CNV Panel
SureSeq™ Myeloid Fusion Panel
SureSeq™ Myeloid MRD Panel
SureSeq™ Myeloid Plus Panel
SureSeq™ Pan-Myeloid Panel
›
Details
Evidence
News
Filter by
Latest
10ms
Strong p53 Expression Over 30% Associates with TP53 Mutations in Transformed DLBCL and DLBCL-NOS (USCAP 2024)
Strong p53 by IHC in more than 30% of neoplastic cells is a useful tool to screen TP53 mutations. In our series, aLBCL did not have significant concurrent alterations between p53 and MYC pathways.
10 months ago
TP53 (Tumor protein P53)
|
TP53 mutation • TP53 deletion • MYC rearrangement • TP53 expression
|
P53 (TP53) Deletion FISH Probe Kit
Share
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login